Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Coagulation factor VII

Coagulation factor VII

Brief Information

Name:Coagulation factor VII
Target Synonym:EC 3.4.21,Eptacog alfa,F7,Coagulation Factor VII,Coagulation Factor VII (Serum Prothrombin Conversion Accelerator),FVII Coagulation Protein,SPCA,EC 3.4.21.21,Factor VII,Proconvertin,Serum prothrombin conversion accelerator,EC:3.4.21.21
Number of Launched Drugs:19
Number of Drugs in Clinical Trials:10
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

COI-M52H1-MALS-HPLC
Coagulation factor VII MALS images

The purity of Mouse Coagulation factor VII, His Tag (Cat. No. COI-M52H1) is more than 90% and the molecular weight of this protein is around 60-80 kDa verified by SEC-MALS.

TF7-H52H5-MALS-HPLC
Coagulation factor VII MALS images

The purity of Human Coagulation factor VII, His Tag (Cat. No. TF7-H52H5) is more than 85% and the molecular weight of this protein is around 50-65 kDa verified by SEC-MALS.

Synonym Name

Coagulation factor VII,F7,SPCA,Proconvertin

Background

Coagulation factor VII is also known as F7, SPCA and Proconvertin. Heterodimer of a light chain and a heavy chain linked by a disulfide bond. Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Human prothrombin complex (Hualan Biological Engineering) Approved Hualan Genetic Engineering Co Ltd Mainland China Blood Coagulation Disorders; Factor X Deficiency Hualan Biological Engineering Inc 1999-01-01 Blood Coagulation Disorders; Hemophilia B; Factor X Deficiency Details
Human prothrombin complex (Sinopharm Shanghai Plasma) Approved Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd Mainland China Hemorrhage Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd 1997-01-01 Hemorrhage Details
Human prothrombin complex (Nanyue Biopharming) Approved Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd Mainland China Hemorrhage Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd 2019-09-05 Hemophilia B; Hemorrhage Details
Prothrombinex-VF (CSL Behring) Approved Csl Behring Llc Australia Hemorrhage Csl Behring Llc 2014-10-01 Hemorrhage Details
Human prothrombin complex (Shanghai Xinxing) Approved Shanghai Xinxing Medicine Co Ltd Mainland China Hemorrhage Shanghai Xinxing Medicine Co Ltd 1997-01-01 Hemorrhage Details
Human prothrombin complex (Guangdong Wellen) Approved Guangdong Wellen Pharmaceutical Co Ltd Mainland China Hemorrhage Guangdong Wellen Pharmaceutical Co Ltd 2020-10-21 Hemophilia B; Hemorrhage Details
Human prothrombin complex (Tonrol Biopharmaceuticals) Approved Tonrol Bio-Pharmaceutical Co Ltd ProthoRAAS Mainland China Hemorrhage Shanghai Raas Blood Products Co Ltd 1996-01-01 Hemophilia B; Hemorrhage Details
Factor IX complex (Grifols) Approved Grifols Sa Profilnine United States Hemophilia B null 1981-07-21 Intracranial Hemorrhages; Hemophilia B Details
Human prothrombin complex (Octapharma) Approved Octapharma Ocplex, Octaplex, Pronativ Germany Hemorrhage Octapharma 2003-03-14 Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Details
Human prothrombin complex (CSL Behring) BE-1116 Approved Csl Behring Llc Kcentra, Beriplex, Confidex Blood Coagulation Disorders; Coagulation Protein Disorders; Heart Failure; Heart Diseases; Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Wounds and Injuries Details
Human prothrombin complex concentrate (Guizhou Taibang Biological Products) Approved Guizhou Taibang Biological Products Co Ltd Mainland China Hypoprothrombinemias Guizhou Taibang Biological Products Co Ltd 2013-07-31 Hypoprothrombinemias Details
Human prothrombin complex (LFB) Approved Lfb Biotechnologies Sas KANOKAD France Hemorrhage Lfb Biotechnologies Sas 2008-09-01 Hemorrhage Details
Human prothrombin complex concentrate (Shanxi Kangbao Biological Products) Approved Shanxi Kangbao Biological Product Co Ltd Mainland China Hemorrhage Shanxi Kangbao Biological Product Co Ltd 2019-09-17 Hemophilia B; Hemorrhage Details
Human prothrombin complex (Boya Bio-Pharmaceutical) Approved Boya Bio-Pharmaceutical Group Co Ltd Mainland China Hemorrhage Boya Bio-Pharmaceutical Group Co Ltd 2020-12-02 Hemophilia B; Hemorrhage Details
Human prothrombin complex (Guangdong Shuanglin) Approved Guangdong Shuanglin Bio-Pharmaceutical Co Ltd Mainland China Hemophilia B Guangdong Shuanglin Bio-Pharmaceutical Co Ltd 2023-05-12 Hemophilia B Details
Anti-inhibitor coagulant complex (Baxalta) Approved Baxalta Incorporated Feiba, Prothromplex TOTAL United States Hemophilia A; Hemophilia B Baxalta Incorporated 1979-12-21 Blood Coagulation Disorders; Blood Coagulation Disorders, Inherited; Hemophilia A; Hemophilia B; Cardiovascular Diseases Details
Prothrombin complex concentrat (Taibang Biological Products) Approved Shandong Taibang Biological Products Co Ltd Mainland China Hemorrhage Shandong Taibang Biological Products Co Ltd 2014-09-30 Hemorrhage; Antithrombin III Deficiency Details
Prothrombin complex concentrate (Sanquin) Approved Sanquin Plasma Products Bv Cofact Hemorrhage Sanquin Plasma Products Bv 2007-11-01 Hemorrhage Details
Human prothrombin complex(Hebei Daan Pharmaceutical) Approved Hebei Daan Pharmaceutical Co Ltd Mainland China Hemorrhage Hebei Daan Pharmaceutical Co Ltd 2020-01-01 Hemophilia B; Hemorrhage Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Human prothrombin complex(Chengdu Rongsheng Pharmaceuticals) Phase 3 Clinical Chengdu Rongsheng Pharmaceuticals Co Ltd Hemophilia B Details
Human prothrombin complex concentrate (Harbin Shiheng Bioengineering Pharmaceutical) Phase 3 Clinical Harbin Pacific Biopharmaceutical Co Ltd Hemophilia B Details
Factor VII (KM Biologics) KD2-305 Phase 3 Clinical Km Biologics Hemophilia A Details
Human prothrombin complex (Lanzhou Lansheng Blood Products) Phase 3 Clinical Lanzhou Lansheng Blood Products Co Ltd Hemophilia B Details
Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical) Phase 3 Clinical Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd Hemophilia B Details
Human prothrombin complex concentrate (Sichuan Yuanda Shuyang Pharmaceutical) Phase 3 Clinical Sichuan Yuanda Shuyang Pharmaceutical Co Ltd Blood Coagulation Disorders Details
HMB-001 HMB001 Phase 2 Clinical Hemab Therapeutics APS Thrombasthenia Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message